{"database":"biostudies-literature","file_versions":[],"scores":null,"additional":{"submitter":["Hamidi M"],"funding":["MCIU/AEI/FEDER, UE","Ikerbasque Research Foundation","Asociación Española Contra el Cancer (AECC)","Asociación Española Contra el Cancer","Basque Government, Department of Education"],"pagination":["4952"],"full_dataset_link":["https://www.ebi.ac.uk/biostudies/studies/S-EPMC9564059"],"repository":["biostudies-literature"],"omics_type":["Unknown"],"volume":["14(19)"],"pubmed_abstract":["E2F1/E2F2 expression correlates with malignancy in prostate cancer (PCa), but its functional significance remains unresolved. To define the mechanisms governed by E2F in PCa, we analyzed the contribution of E2F target genes to the control of genome integrity, and the impact of modulating E2F activity on PCa progression. We show that silencing or inhibiting E2F1/E2F2 induces DNA damage during S phase and potentiates 5-FU-induced replication stress and cellular toxicity. Inhibition of E2F downregulates the expression of E2F targets involved in nucleotide biosynthesis (<i>TK1</i>, <i>DCK</i>, <i>TYMS</i>), whose expression is upregulated by 5-FU. However, their enzymatic products failed to rescue DNA damage of E2F1/E2F2 knockdown cells, suggesting additional mechanisms for E2F function. Inter"],"journal":["Cancers"],"pubmed_title":["Targeting E2F Sensitizes Prostate Cancer Cells to Drug-Induced Replication Stress by Promoting Unscheduled CDK1 Activity."],"pmcid":["PMC9564059"],"funding_grant_id":["RTI2018-097497-B-100","Fellowship","predoctoral fellowship","RED2018-102723-T","IT1547-22","RTI2018-097497-B-100, PID2021-122922OB-100 and RED2018-102723-T","PID2021-124425OB-I00","IT1257-19 and IT1547-22","IT1476-2","IT1257-19","PID2021-122922OB-100"],"pubmed_authors":["Hamidi M","Mitxelena J","Iglesias-Ara A","Aurrekoetxea I","Fernandez-Ares L","Eriz A","Zubiaga AM","Aspichueta P"],"additional_accession":[]},"is_claimable":false,"name":"Targeting E2F Sensitizes Prostate Cancer Cells to Drug-Induced Replication Stress by Promoting Unscheduled CDK1 Activity.","description":"E2F1/E2F2 expression correlates with malignancy in prostate cancer (PCa), but its functional significance remains unresolved. To define the mechanisms governed by E2F in PCa, we analyzed the contribution of E2F target genes to the control of genome integrity, and the impact of modulating E2F activity on PCa progression. We show that silencing or inhibiting E2F1/E2F2 induces DNA damage during S phase and potentiates 5-FU-induced replication stress and cellular toxicity. Inhibition of E2F downregulates the expression of E2F targets involved in nucleotide biosynthesis (<i>TK1</i>, <i>DCK</i>, <i>TYMS</i>), whose expression is upregulated by 5-FU. However, their enzymatic products failed to rescue DNA damage of E2F1/E2F2 knockdown cells, suggesting additional mechanisms for E2F function. Inter","dates":{"release":"2022-01-01T00:00:00Z","publication":"2022 Oct","modification":"2026-04-08T11:52:07.966Z","creation":"2025-04-05T11:03:30.436Z"},"accession":"S-EPMC9564059","cross_references":{"pubmed":["36230876"],"doi":["10.3390/cancers14194952"]}}